Hospital Universitari de Bellvitge Report issue

Academic/Hospital Phase 2 Phase 4

Organization Overview

First Clinical Trial
2006
NCT00396721
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Daniel Podzamczer | Isabel Lopez Zamora | José María Piulats Rodríguez | Josep Maria Ramon Torrell, PhD | Josep m Cruzado | Josep M Cruzado | M. Carmen Cabellos Minguez | Miguel Santín | Núria Sabé Fernàndez | Sebastian Videla | Unidad de Trasplante Renal - Hospital Universitari de Bellvitge